3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Breast Neoplasms
12
Neoplasms
8
Prostatic Neoplasms
4
Neoplasm Metastasis
4
Lung Neoplasms
3
Gastrointestinal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Brain Neoplasms
3
Sarcoma
2
Pain
2
Multiple Myeloma
2
Melanoma
2
Hematologic Neoplasms
2
Fatigue
2
Esophageal Neoplasms
2
Carcinoma, Hepatocellular
2
Weight Loss
1
Uterine Cervical Neoplasms
1
To Observe Whether the Fucoidan Can Improve the Quality of Life of the Such Patients Receiving the Neoadjuvant CCRT
1
Thymus Neoplasms
1
Thrombocytopenia
1
Symptom Management
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Splenomegaly
1
Speech
1
Sexual Dysfunction, Physiological
1
Sex Cord-Gonadal Stromal Tumors
1
Sarcoma, Synovial
1
Rectal Neoplasms
1
Interventions
Cyclophosphamide
184
fludarabine phosphate
162
fludarabine
128
Busulfan
116
Tacrolimus
109
Mycophenolic Acid
101
Whole-Body Irradiation
97
Antilymphocyte Serum
87
Peripheral Blood Stem Cell Transplantation
84
Azacitidine
82
Melphalan
81
Filgrastim
74
Cytarabine
74
Cyclosporine
72
Methotrexate
64
Decitabine
57
Granulocyte Colony-Stimulating Factor
51
Thiotepa
45
Radiotherapy
41
thymoglobulin
40
Stem Cell Transplantation
40
Cord Blood Stem Cell Transplantation
40
venetoclax
39
Clofarabine
35
Sirolimus
30
Methylprednisolone
30
Specimen Handling
27
Etoposide
24
Alemtuzumab
24
Biopsy
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Myelodysplastic Syndromes
×
Quality of Life
×
Clear all
NCT07387354
2026-03-16
MDS
Thomas Jefferson University
Phase 1/2
Not yet recruiting
25 enrolled